SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017499
Filing Date
2019-11-14
Accepted
2019-11-14 16:29:56
Documents
64
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 785139
2 ex10-1.htm EX-10.1 201813
3 ex31-1.htm EX-31.1 16912
4 ex31-2.htm EX-31.2 16707
5 ex32-1.htm EX-32.1 9814
  Complete submission text file 0001493152-19-017499.txt   4047277

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE eton-20190930.xml EX-101.INS 515645
7 XBRL SCHEMA FILE eton-20190930.xsd EX-101.SCH 48166
8 XBRL CALCULATION FILE eton-20190930_cal.xml EX-101.CAL 45448
9 XBRL DEFINITION FILE eton-20190930_def.xml EX-101.DEF 215218
10 XBRL LABEL FILE eton-20190930_lab.xml EX-101.LAB 353251
11 XBRL PRESENTATION FILE eton-20190930_pre.xml EX-101.PRE 282000
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 191220830
SIC: 2834 Pharmaceutical Preparations